价格

Endoceutics, Inc.

ACTIVE

Unknown Belgian address, Unknown, 比利时www.endoceutics.comHolding101–250 名员工成立于: 2006-01-01

别名:

clinique de recherche des traitements hormonaux

endoceutics s.a.

概览

试验阶段分布

阶段

试验数

占比

3 期

100.0%

试验状态分布

已完成

77.8%

撤回

22.2%

相关临床试验

该机构主办的试验（9）

Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study

Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer

Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)

Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause

Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women

第 1 页，共 2 页

药物批准

按机构分类的批准

EMA

European Medicines Agency

药物批准

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

药物批准

近期批准

INTRAROSA 6,5 MG OVULOS

资讯

暂无资讯文章

返回机构列表

Endoceutics, Inc.

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（9）

Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study

Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer

Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)

Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause

Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women

Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study

DHEA Against Vaginal Atrophy - Safety Study of 12 Months

药物批准

按机构分类的批准

近期批准

资讯